Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Cited In for PubMed (Select 18628378)

1.

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer.

Ng L, Wan T, Chow A, Iyer D, Man J, Chen G, Yau TC, Lo O, Foo CC, Poon JT, Poon RT, Pang R, Law WL.

Stem Cells Int. 2015;2015:247892. doi: 10.1155/2015/247892. Epub 2015 May 27.

2.

Serum GRO╬▓: a potential tumor-associated biomarker for colorectal cancer.

Zheng Z, Zheng M, Bi J, Feng Q, Yue Z, Zhou Y, Hu W, Zhang H, Gao H.

Int J Clin Exp Med. 2015 Feb 15;8(2):2526-35. eCollection 2015.

3.

Regret on choice of colorectal cancer screening modality was associated with poorer screening compliance: a 4-year prospective cohort study.

Wong MC, Ching JY, Chan VC, Bruggemann R, Lam TY, Luk AK, Wu JC, Chan FK, Sung JJ.

PLoS One. 2015 Apr 14;10(4):e0125782. doi: 10.1371/journal.pone.0125782. eCollection 2015.

4.

Age and site of Colonic Neoplastic Lesions: Implications of screening in South Asia.

Hussain M, Khalid AB, Ahsan S, Jafri W, Hamid S, Javed A, Wahab S.

Pak J Med Sci. 2014 Nov-Dec;30(6):1277-80. doi: 10.12669/pjms.306.5701.

5.

Detection of miRNA as non-invasive biomarkers of colorectal cancer.

Ren A, Dong Y, Tsoi H, Yu J.

Int J Mol Sci. 2015 Jan 27;16(2):2810-23. doi: 10.3390/ijms16022810.

6.

Should prior FIT results be incorporated as an additional variable to estimate risk of colorectal neoplasia? A prospective study of 5,813 screening colonoscopies.

Wong MC, Ching JY, Chan VC, Shum JP, Lam TY, Luk AK, Sung JJ.

PLoS One. 2014 Dec 5;9(12):e114332. doi: 10.1371/journal.pone.0114332. eCollection 2014.

7.

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.

Chen J, Guo F, Shi X, Zhang L, Zhang A, Jin H, He Y.

BMC Cancer. 2014 Nov 3;14:802. doi: 10.1186/1471-2407-14-802.

8.

MicroRNA dysregulation as a prognostic biomarker in colorectal cancer.

Dong Y, Yu J, Ng SS.

Cancer Manag Res. 2014 Oct 14;6:405-22. doi: 10.2147/CMAR.S35164. eCollection 2014. Review.

9.

Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy.

Chan WK, Azmi N, Mahadeva S, Goh KL.

World J Gastroenterol. 2014 Oct 21;20(39):14488-94. doi: 10.3748/wjg.v20.i39.14488.

10.

Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations.

Huang W, Liu G, Zhang X, Fu W, Zheng S, Wu Q, Liu C, Liu Y, Cai S, Huang Y.

PLoS One. 2014 Oct 6;9(10):e109150. doi: 10.1371/journal.pone.0109150. eCollection 2014.

11.

Assessment of risk factors for delayed colonic post-polypectomy hemorrhage: a study of 15553 polypectomies from 2005 to 2013.

Zhang Q, An Sl, Chen Zy, Fu FH, Jiang B, Zhi Fc, Bai Y, Gong W.

PLoS One. 2014 Oct 1;9(10):e108290. doi: 10.1371/journal.pone.0108290. eCollection 2014.

12.

Characteristics of colorectal polyps and cancer; a retrospective review of colonoscopy data in iran.

Delavari A, Mardan F, Salimzadeh H, Bishehsari F, Khosravi P, Khanehzad M, Nasseri-Moghaddam S, Merat S, Ansari R, Vahedi H, Shahbazkhani B, Saberifiroozi M, Sotoudeh M, Malekzadeh R.

Middle East J Dig Dis. 2014 Jul;6(3):144-50.

13.

Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country.

Zahir MN, Azhar EM, Rafiq S, Ghias K, Shabbir-Moosajee M.

ISRN Oncol. 2014 Apr 1;2014:461570. doi: 10.1155/2014/461570. eCollection 2014.

14.

Single nucleotide polymorphisms associated with colorectal cancer susceptibility and loss of heterozygosity in a Taiwanese population.

Yang CY, Lu RH, Lin CH, Jen CH, Tung CY, Yang SH, Lin JK, Jiang JK, Lin CH.

PLoS One. 2014 Jun 26;9(6):e100060. doi: 10.1371/journal.pone.0100060. eCollection 2014.

16.

Developing screening services for colorectal cancer on Android smartphones.

Wu HC, Chang CJ, Lin CC, Tsai MC, Chang CC, Tseng MH.

Telemed J E Health. 2014 Aug;20(8):687-95. doi: 10.1089/tmj.2013.0288. Epub 2014 May 21.

PMID:
24848873
17.

ESD training: A challenging path to excellence.

Herreros de Tejada A.

World J Gastrointest Endosc. 2014 Apr 16;6(4):112-20. doi: 10.4253/wjge.v6.i4.112. Review.

18.

Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER database.

Li Q, Cai G, Li D, Wang Y, Zhuo C, Cai S.

PLoS One. 2014 Apr 3;9(4):e93756. doi: 10.1371/journal.pone.0093756. eCollection 2014.

19.

Validity of fecal occult blood test in the national cancer screening program, Korea.

Shin A, Choi KS, Jun JK, Noh DK, Suh M, Jung KW, Kim BC, Oh JH, Park EC.

PLoS One. 2013 Nov 8;8(11):e79292. doi: 10.1371/journal.pone.0079292. eCollection 2013.

20.

Barriers to colorectal cancer screening in the developing world: The view from Pakistan.

Ahmed F.

World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):83-5. doi: 10.4292/wjgpt.v4.i4.83.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk